ARA-290 – EPO-Derived Tissue-Protective Peptide

ARA-290 is a synthetic peptide derived from
erythropoietin (EPO),
specifically engineered to retain tissue-protective signaling properties without stimulating red blood cell production.
This selective activity makes it a key compound in research exploring inflammation, cellular repair, and nerve function.

This vial contains 10mg of high-purity ARA-290, produced under strict laboratory standards for in vitro research use.

Research Applications

• Inflammatory pathway modulation studies
• Tissue repair and regeneration models
• Neurological and nerve function research
• Cellular protection and stress-response studies
• Immune system signaling investigations

Scientific Background

ARA-290 selectively activates the innate repair receptor (IRR), a heteromeric receptor complex related to the
erythropoietin receptor.
Unlike traditional EPO, ARA-290 does not stimulate erythropoiesis, allowing researchers to isolate its tissue-protective and anti-inflammatory signaling pathways.

In experimental models, ARA-290 has been studied for its role in reducing inflammatory cytokine activity and supporting cellular resilience in stressed environments, particularly in neural and vascular tissues.

Chemical Profile

Type: EPO-derived peptide analog
Target: Innate repair receptor (IRR)
Form: Lyophilized powder
Purity: ≥98% (HPLC)

Manufactured under controlled laboratory conditions for research use only.

Storage & Handling

Store at −20°C in a dry, light-protected environment. After reconstitution, refrigerate at 2–8°C and avoid repeated freeze–thaw cycles.

For Research Use Only

ARA-290 10mg is intended strictly for in vitro laboratory research and is not for human or veterinary use.

• Erythropoietin – Wikipedia
• EPO Receptor – Wikipedia
• Inflammation – Wikipedia